Amicus (FOLD) Flies to 52-Week High on $5-Billion BioMarin Merger
Amicus Therapeutics soared to a new 52-week high on Friday, jumping 30.21 percent to close at $14.18 apiece as investors gobbled up shares following announcements that it would merge with Biomarin Pharmaceutical...







